These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characterization of the stage of progression in hepatocarcinogenesis in the rat. Pitot HC Basic Life Sci; 1991; 57():3-18. PubMed ID: 1814289 [No Abstract] [Full Text] [Related]
8. Genetic instability occurs sooner than expected: promotion, progression and clonality during hepatocarcinogenesis in the rat. Sudilovsky O; Hinrichsen LI; Hei TK; Whitacre CM; Wang JH; Kasturi S; Jiang SH; Cechner R; Miron S; Abdul-Karim F Basic Life Sci; 1991; 57():263-77. PubMed ID: 1667572 [No Abstract] [Full Text] [Related]
9. Triggering the cellular change to neoplasia. Pitot HC Urology; 1984 Apr; 23(4 Suppl):9-17. PubMed ID: 6369723 [No Abstract] [Full Text] [Related]
10. Chemical carcinogenesis: the liver as a model. Farber E; Sarma DS Pathol Immunopathol Res; 1986; 5(1):1-28. PubMed ID: 3022277 [No Abstract] [Full Text] [Related]
11. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Schulte-Hermann R; Bursch W; Kraupp-Grasl B; Oberhammer F; Wagner A; Jirtle R Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):87-90. PubMed ID: 8013429 [TBL] [Abstract][Full Text] [Related]
13. Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions. Burkholder I; Kopp-Schneider A Math Biosci; 2002; 179(2):145-60. PubMed ID: 12208613 [TBL] [Abstract][Full Text] [Related]
14. Tumor promotion in the liver. Schulte-Hermann R Arch Toxicol; 1985 Aug; 57(3):147-58. PubMed ID: 3904674 [No Abstract] [Full Text] [Related]
15. Genetic susceptibility to tumor progression in mouse skin carcinogenesis. Stern MC; Conti CJ Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983 [No Abstract] [Full Text] [Related]
16. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events. Kopp-Schneider A; Portier C; Bannasch P Math Biosci; 1998 Mar; 148(2):181-204. PubMed ID: 9610106 [TBL] [Abstract][Full Text] [Related]
17. Trends in pathobiochemical studies of tumour development and progression. Jeney A Acta Morphol Hung; 1986; 34(4):311-23. PubMed ID: 3118648 [No Abstract] [Full Text] [Related]
18. Role of tumor suppressor genes in a multistep model of carcinogenesis. Boyd JA; Barrett JC Basic Life Sci; 1991; 57():183-94; discussion 194-6. PubMed ID: 1814282 [No Abstract] [Full Text] [Related]
19. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Grasl-Kraupp B; Ruttkay-Nedecky B; Müllauer L; Taper H; Huber W; Bursch W; Schulte-Hermann R Hepatology; 1997 Apr; 25(4):906-12. PubMed ID: 9096596 [TBL] [Abstract][Full Text] [Related]
20. Cellular events during hepatocarcinogenesis in rats and the question of premalignancy. Sell S; Hunt JM; Knoll BJ; Dunsford HA Adv Cancer Res; 1987; 48():37-111. PubMed ID: 2441577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]